• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Roche & Quest Establish Toeholds in Emerging Alzheimer’s Blood Testing Market

Roche & Quest Establish Toeholds in Emerging Alzheimer’s Blood Testing Market

by Glenn S. Demby | Nov 29, 2023 | Deals-lir, Essential, Lab Industry Advisor

While Roche has an early lead, Quest recently made key moves to improve its position in the AD patient-initiated blood testing market.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Can Ophthalmic Biomarkers Offer Insights into Brain Pathologies?

Can Ophthalmic Biomarkers Offer Insights into Brain Pathologies?

by Michael Schubert, PhD | Jul 31, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

Protein levels in the vitreous humor may have the potential to support the diagnosis and staging of neurodegenerative diseases.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Easier, Noninvasive Diagnosis of Neurological Disorders

by Glenn S. Demby | Jan 26, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Roche Alzheimer’s Early Detection Tests Get FDA Green Light

by Glenn S. Demby | Dec 22, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, FDA-dtet

In this month’s diagnostics pipeline report, Roche gets clearance for two new Alzheimer’s early detection tests.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Which Blood Tests Are Best at Early Alzheimer’s Detection?

Which Blood Tests Are Best at Early Alzheimer’s Detection?

by Rachel Muenz | Dec 6, 2022 | News, Open Content

A recent study led by a team at the University of Gothenburg shows that multiple biomarkers could ID the disease even in people with no symptoms.

« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com